Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Lederer et al.

Published: 31 January 2022| Version 1 | DOI: 10.17632/c58ngv5mm7.1
Contributors:
Katlyn Lederer, Emily Bettini, Michela Locci

Description

Supplementary Table 4. Cell populations from FNA and PBMC samples, related to Figures 1-5 and S1-6. Data are displayed as a percentage of lymphocytes.

Files

Categories

Flow Cytometry

Licence